Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.67 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.52 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.52 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.50 |
| ▸ | PPARG | P37231 | 4/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.50 |
| ▸ | F7 | P08709 | 3/20 | 0.50 |
| ▸ | F3 | P13726 | 3/20 | 0.50 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.50 |
| ▸ | PPARD | Q03181 | 2/20 | 0.50 |
| ▸ | PPARA | Q07869 | 2/20 | 0.50 |
| ▸ | RXRA | P19793 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5941119 | 1.00 | KDM4E (0.67) | KDM4EKMT2AMEN1RECQLPTGS2 | |
| SCHEMBL16800400 | 0.95 | KDM4E (0.64) | KDM4EKMT2AMEN1RECQLPTGS2 | |
| SCHEMBL16770315 | 0.95 | KDM4E (0.64) | KDM4EKMT2AMEN1RECQLPTGS2 | |
| SCHEMBL17369040 | 0.95 | KDM4E (0.64) | KDM4EKMT2AMEN1RECQLPTGS2 | |
| SCHEMBL455959 | 0.92 | KDM4E (0.62) | KDM4EKMT2AMEN1RECQLPTGS2 | |
| SCHEMBL455960 | 0.92 | KDM4E (0.62) | KDM4EKMT2AMEN1RECQLPTGS2 | |
| SCHEMBL469589 | 0.92 | KDM4E (0.62) | KDM4EKMT2AMEN1RECQLPTGS2 | |
| SCHEMBL16800410 | 0.91 | KDM4E (0.73) | KDM4EKMT2AMEN1RECQLALDH1A1 | |
| SCHEMBL8814970 | 0.91 | KDM4E (0.73) | KDM4EKMT2AMEN1RECQLALDH1A1 | |
| SCHEMBL8814964 | 0.91 | KDM4E (0.73) | KDM4EKMT2AMEN1RECQLALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150374839-A1 | NOVEL FATTY ACID-SALICYLATE CONJUGATES WITH ENHANCED THERAPEUTIC PROPERTIES | KEAN UNIVERSITY (US) | 2015-12-31 | — | — | US | disclosed |
| US-20150374839-A1 | NOVEL FATTY ACID-SALICYLATE CONJUGATES WITH ENHANCED THERAPEUTIC PROPERTIES | KEAN UNIVERSITY (US) | 2015-12-31 | — | — | US | disclosed |
| US-9056139-B2 | Fatty acid-salicylate conjugates with enhanced therapeutic properties | KEAN UNIVERSITY (US) | 2015-06-16 | — | — | US | disclosed |
| US-9056139-B2 | Fatty acid-salicylate conjugates with enhanced therapeutic properties | KEAN UNIVERSITY (US) | 2015-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150374839-A1 | NOVEL FATTY ACID-SALICYLATE CONJUGATES WITH ENHANCED THERAPEUTIC PROPERTIES | FASN, ELOVL1, ELOVL3 | KDM4E 2152/4885KMT2A 2301/4885MEN1 4457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.